Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): a 12-month longitudinal study.
Saved in:
| Title: | Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): a 12-month longitudinal study. |
|---|---|
| Authors: | Corsini CA; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil., Campos GRF; Faculty of Medicine of São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil., Martins PFDS; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil., Filgueiras PS; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil., Lima AES; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil., Gomes SVC; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil., Curimbaba CAL; Instituto Butantan, São Paulo, São Paulo, Brazil., Lorencini DA; Instituto Butantan, São Paulo, São Paulo, Brazil., Morandi Junior E; Instituto Butantan, São Paulo, São Paulo, Brazil., da Silva VM; Instituto Butantan, São Paulo, São Paulo, Brazil., Cervi MC; Faculty of Medicine, University of São Paulo (USP), São Paulo, São Paulo, Brazil., Borges MC; Faculty of Medicine, University of São Paulo (USP), São Paulo, São Paulo, Brazil.; Serrana Clinical Research Center, Serrana, São Paulo, Brazil., de Lima PR; Serrana Clinical Research Center, Serrana, São Paulo, Brazil., do Nascimento JPR; Serrana Clinical Research Center, Serrana, São Paulo, Brazil., Correa PRL; Belo Horizonte Municipal Health Department (SMS), Belo Horizonte, Brazil., Castilho LDR; Cell Culture Engineering Laboratory (COPPE), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Rio de Janeiro, Brazil., de Oliveira JG; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil., Filho OAM; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil., Nogueira ML; Faculty of Medicine of São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil.; Hospital de Base, São José do Rio Preto, São Paulo, Brazil.; Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States., Grenfell RFQE; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil.; Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.; Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia (UGA), Athens, GA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Jul 15; Vol. 16, pp. 1589733. Date of Electronic Publication: 2025 Jul 15 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40735326 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): a 12-month longitudinal study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Corsini+CA%22">Corsini CA</searchLink>; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil.<br /><searchLink fieldCode="AU" term="%22Campos+GRF%22">Campos GRF</searchLink>; Faculty of Medicine of São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Martins+PFDS%22">Martins PFDS</searchLink>; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil.<br /><searchLink fieldCode="AU" term="%22Filgueiras+PS%22">Filgueiras PS</searchLink>; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil.<br /><searchLink fieldCode="AU" term="%22Lima+AES%22">Lima AES</searchLink>; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil.<br /><searchLink fieldCode="AU" term="%22Gomes+SVC%22">Gomes SVC</searchLink>; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil.<br /><searchLink fieldCode="AU" term="%22Curimbaba+CAL%22">Curimbaba CAL</searchLink>; Instituto Butantan, São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Lorencini+DA%22">Lorencini DA</searchLink>; Instituto Butantan, São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Morandi+Junior+E%22">Morandi Junior E</searchLink>; Instituto Butantan, São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22da+Silva+VM%22">da Silva VM</searchLink>; Instituto Butantan, São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Cervi+MC%22">Cervi MC</searchLink>; Faculty of Medicine, University of São Paulo (USP), São Paulo, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Borges+MC%22">Borges MC</searchLink>; Faculty of Medicine, University of São Paulo (USP), São Paulo, São Paulo, Brazil.; Serrana Clinical Research Center, Serrana, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22de+Lima+PR%22">de Lima PR</searchLink>; Serrana Clinical Research Center, Serrana, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22do+Nascimento+JPR%22">do Nascimento JPR</searchLink>; Serrana Clinical Research Center, Serrana, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Correa+PRL%22">Correa PRL</searchLink>; Belo Horizonte Municipal Health Department (SMS), Belo Horizonte, Brazil.<br /><searchLink fieldCode="AU" term="%22Castilho+LDR%22">Castilho LDR</searchLink>; Cell Culture Engineering Laboratory (COPPE), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22de+Oliveira+JG%22">de Oliveira JG</searchLink>; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil.<br /><searchLink fieldCode="AU" term="%22Filho+OAM%22">Filho OAM</searchLink>; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil.<br /><searchLink fieldCode="AU" term="%22Nogueira+ML%22">Nogueira ML</searchLink>; Faculty of Medicine of São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil.; Hospital de Base, São José do Rio Preto, São Paulo, Brazil.; Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Grenfell+RFQE%22">Grenfell RFQE</searchLink>; Instituto René Rachou, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil.; Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.; Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia (UGA), Athens, GA, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Jul 15; Vol. 16, pp. 1589733. <i>Date of Electronic Publication: </i>2025 Jul 15 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40735326 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2025.1589733 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1589733 Titles: – TitleFull: Neutralizing antibody response to Omicron subvariants BA.1 and BA.5 in children and adolescents following the two-dose CoronaVac protocol (Immunita-002, Brazil): a 12-month longitudinal study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Corsini CA – PersonEntity: Name: NameFull: Campos GRF – PersonEntity: Name: NameFull: Martins PFDS – PersonEntity: Name: NameFull: Filgueiras PS – PersonEntity: Name: NameFull: Lima AES – PersonEntity: Name: NameFull: Gomes SVC – PersonEntity: Name: NameFull: Curimbaba CAL – PersonEntity: Name: NameFull: Lorencini DA – PersonEntity: Name: NameFull: Morandi Junior E – PersonEntity: Name: NameFull: da Silva VM – PersonEntity: Name: NameFull: Cervi MC – PersonEntity: Name: NameFull: Borges MC – PersonEntity: Name: NameFull: de Lima PR – PersonEntity: Name: NameFull: do Nascimento JPR – PersonEntity: Name: NameFull: Correa PRL – PersonEntity: Name: NameFull: Castilho LDR – PersonEntity: Name: NameFull: de Oliveira JG – PersonEntity: Name: NameFull: Filho OAM – PersonEntity: Name: NameFull: Nogueira ML – PersonEntity: Name: NameFull: Grenfell RFQE IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 07 Text: 2025 Jul 15 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
